Skip to main content

Psychopharmacotherapy of Trauma Sequelae

  • Chapter
  • First Online:
Trauma Sequelae
  • 1116 Accesses

Abstract

In the treatment of posttraumatic stress disorder (PTSD) – the most clinically relevant trauma sequelae in literature and clinical practice – psychopharmacotherapy has a subordinate role compared to psychotherapeutic procedures. Compared to the relatively large number of publications on posttraumatic disorders and their psychotherapeutic treatment, there are comparatively few studies on the therapeutic use of psychotropic substances. According to the current state of knowledge, psychopharmacotherapy nevertheless represents a useful addition to the overall treatment plan of posttraumatic disorders, which is indicated in particular for severe PTSD syndromes with hyperexcitability, panic attacks and depressive symptoms, if possible in combination with psychotherapy. First choice drugs for posttraumatic stress disorder are antidepressants from the SSRI group (e.g. sertraline, paroxetine) or pharmacologically similar substances.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literature

  • Ahearn, E. P., Juergens, T., Cordes, T., Becker, T., & Krahn, D. (2011). A review of atypical antipsychotic medications for posttraumatic stress disorder. International Clinical Psychopharmacology, 26(4), 193–200.

    PubMed  Google Scholar 

  • Amos, T., Stein, D. J., & Ipser, J. C. (2014). Pharmacological interventions for preventing post-traumatic stress disorder (PTBS). Cochrane Database of Systematic Reviews, 8, CD006239.

    Google Scholar 

  • APA (American Psychiatric Association). (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). American Psychiatric Association.

    Google Scholar 

  • Asnis, G. M., Kohn, S. R., Henderson, M., & Brown, N. L. (2004). SSRIs versus non-SSRIs in post-traumatic stress disorder: An update with recommendations. Drugs, 64(4), 383–404.

    Article  CAS  PubMed  Google Scholar 

  • Baker, D. G., Diamond, B. I., Gillette, G., Hamner, M., Katzelnick, D., Keller, T., Mellman, T. A., Pontius, E., Rosenthal, M., & Tucker, P. (1995). A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology, 122, 386–389.

    Article  CAS  PubMed  Google Scholar 

  • Bauer, M., & Berghöfer, A. (1997). Leitlinien und praktische Durchführung der Pharmakotherapie mit Antidepressiva. In M. Bauer & A. Berghöfer (Eds.), Therapieresistente Depressionen. Springer.

    Chapter  Google Scholar 

  • Bauer, M., Pfennig, A., Severus, E., et al. (2013). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders. World Journal of Biological Psychiatry, 14, 334–385.

    Article  Google Scholar 

  • Bauer, M., Severus, E., Köhler, S., et al. (2015). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 2: Maintenance treatment of major depressive disorder-update 2015. World Journal of Biological Psychiatry, 16, 76–95.

    Article  Google Scholar 

  • Becker, M. E., Hertzberg, M. A., Moore, S. D., Dennis, M. F., Bukenya, D. S., & Beckham, J. C. (2007). A placebocontrolled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 27, 193–197.

    Article  CAS  PubMed  Google Scholar 

  • Berger, W., Mendlowicz, M. V., Marques-Portella, C., Kinrys, G., Fontenelle, L. F., Marmar, C. R., & Figueira, I. (2009). Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33, 169–180.

    Article  CAS  PubMed  Google Scholar 

  • Berlin, H. A. (2007). Antiepileptic drugs for the treatment of post-traumatic stress disorder. Current Psychiatry Reports, 9, 291–300.

    Article  PubMed  Google Scholar 

  • Bonne, O., Grillon, C., Vythilingam, M., Neumeister, A., & Charney, D. S. (2004). Adaptive and maladaptive psychobiological responses to severe psychological stress: Implications for the discovery of novel pharmacotherapy. Neuroscience of Biobehavioral Reviews, 28(1), 65–94.

    Article  Google Scholar 

  • Brady, K. T., Killeen, T. K., Brewerton, T., & Lucerini, S. (2000). Comorbidity of psychiatric disorders and posttraumatic stress disorder. Journal of Clinical Psychiatry, 61(suppl. 7), 22–32.

    Google Scholar 

  • Braun, P., Greenberg, D., Dasberg, H., & Lerer, B. (1990). Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. Journal of Clinical Psychiatry, 51, 236–238.

    CAS  Google Scholar 

  • Carey, P., Suliman, S., Ganesan, K., Seedat, S., & Stein, D. J. (2012). Olanzapine monotherapy in posttraumatic stress disorder: Efficacy in a randomized, double-blind, placebo-controlled study. Human Psychopharmacology, 27, 386–391.

    Article  CAS  PubMed  Google Scholar 

  • Charney, D. S., Deutch, A. Y., Krystal, J. H., Southwick, S. M., & Davis, M. (1993). Psychobiologic mechanisms of posttraumatic stress disorder. Archives of General Psychiatry, 50, 294–305.

    Article  CAS  Google Scholar 

  • Cipriani, A., Williams, T., Nikolakopoulou, A., et al. (2017). Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: A network meta-analysis. Psychological Medicine, 19, 1–10.

    Google Scholar 

  • Davidson, J. (1992). Drug therapy of post-traumatic stress disorder. British Journal of Psychiatry, 160, 309–314.

    Article  CAS  Google Scholar 

  • Davidson, J. (2006). Pharmacologic treatment of acute and chronic stress following trauma. Journal of Clinical Psychiatry, 67(suppl 2), 34–39.

    CAS  Google Scholar 

  • Davidson, J., Kudler, H., Smith, R., Mahorney, S. L., Lipper, S., Hammett, E., Saunders, W. B., & Cavenar, J. O. (1990). Treatment of posttraumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry, 47, 259–266.

    Article  CAS  PubMed  Google Scholar 

  • Ebbinghaus, R., Bauer, M., & Priebe, S. (1996). Behandlung der posttraumatischen Belastungsstörung. Eine Übersicht. Fortschritte der Neurologie, Psychiatrie, 64, 433–443.

    Article  CAS  Google Scholar 

  • Foa, E. B., Davidson, J. R. T., & Frances, A. (1999). The expert consensus guidelines series: Treatment of posttraumatic stress disorder. Journal of Clinical Psychiatry, 60(suppl. 16), 1–76.

    Google Scholar 

  • Friedman, M. J. (1988). Toward rational pharmacotherapy for posttraumatic stress disorder: An interim report. American Journal of Psychiatry, 145, 281–285.

    Article  CAS  Google Scholar 

  • Gelpin, E., Bonne, O., Peri, T., Brandes, D., & Shalev, A. Y. (1996). Treatment of recent trauma survivors with benzodiazepines: A prospective study. Journal of Clinical Psychiatry, 57, 390–394.

    CAS  Google Scholar 

  • Gersons, B. P. R., & Denis, D. (1996). Das Konzept der posttraumatischen Belastungsstörung. In S. Priebe, D. Denis, & M. Bauer (Eds.), Eingesperrt und nie mehr frei. Psychisches Leiden nach politischer Haft in der DDR. Steinkopff.

    Google Scholar 

  • Giourou, E., Skokou, M., Andrew, S. P., Alexopoulou, K., Gourzis, P., & Jelastopulu, E. (2018). Complex posttraumatic stress disorder: The need to consolidate a distinct clinical syndrome or to reevaluate features of psychiatric disorders following interpersonal trauma? World Journal of Psychiatry, 22, 12–19.

    Article  Google Scholar 

  • Hageman, I., Andersen, H. S., & Jorgensen, M. B. (2001). Post-traumatic stress disorder: A review of psychobiology and pharmacotherapy. Acta Psychiatrica Scandinavica, 104, 411–422.

    Article  CAS  PubMed  Google Scholar 

  • Hollweg, M., & Soyka, M. (1996). Benzodiazepine – Indikationen, unerwünschte Arzneimittelwirkungen und Risiken bei Langzeitbehandlung. Psychopharmakotherapie, 4, 161–167.

    Google Scholar 

  • Hoskins, M., Pearche, J., Bethell, A., et al. (2015). Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis. British Journal of Psychiatry, 206, 93–100.

    Article  Google Scholar 

  • Ipser, J. C., & Stein, D. J. (2012). Evidence-based pharmacotherapy of post-traumatic stress disorder (PTBS). International Journal of Neuropsychopharmacology, 15, 825–840.

    Article  CAS  Google Scholar 

  • Kosten, T. R., Frank, J. B., Dan, E., McDougle, C. J., & Giller, E. L. (1991). Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. Journal of Nervous and Mental Disease, 179, 366–370.

    Article  CAS  Google Scholar 

  • Maercker, A., & Augsburger, M. (2017). Psychotraumatologie. Nervenarzt, 88, 967–973.

    Article  CAS  PubMed  Google Scholar 

  • Müller-Oerlinghausen, B., Berghöfer, A., & Bauer, M. (2002). Bipolar disorder. Lancet, 359, 241–224.

    Article  PubMed  Google Scholar 

  • Neal, L. A., Shapland, W., & Fox, C. (1997). An open trial of moclobemide in the treatment of post-traumatic stress disorder. International Clinical Psychopharmacology, 12, 231–237.

    Article  CAS  PubMed  Google Scholar 

  • Nobles, C. J., Valentine, S. E., & Zepeda, E. D. (2017). Usual course of treatment and predictors of treatment utilization for patients with posttraumatic stress disorder. Journal of Clinical Psychiatry, 78(suppl. 5), e559–e566.

    Article  Google Scholar 

  • Pae, C. U., Lim, H. K., Peindl, K., Ajwani, N., Serretti, A., Patkar, A. A., & Lee, C. (2008). The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials. International Clinical Psychopharmacology, 23(1), 1–8.

    Article  PubMed  Google Scholar 

  • Post, R. M., & Weiss, S. R. B. (1989). Sensitization, kindling, and anticonvulsants in mania. Journal of Clinical Psychiatry, 50(suppl. 12), 23–30.

    Google Scholar 

  • Raskind, M. A., Peskind, E. R., Chow, B., et al. (2018). Trial of prazosin for post-traumatic stress disorder in military veterans. The New England Journal of Medicine, 378, 507–517.

    Article  CAS  PubMed  Google Scholar 

  • Reist, C., Kauffmann, C. D., Haier, R. J., Sangdahl, C., DeMet, E. M., Chicz-DeMet, A., & Nelson, J. N. (1989). A controlled trial of desipramine in 18 men with posttraumatic stress disorder. American Journal of Psychiatry, 146, 513–516.

    Article  CAS  Google Scholar 

  • Shestatzky, M., Greenberg, D., & Lerer, B. (1988). A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Research, 24, 149–155.

    Article  CAS  PubMed  Google Scholar 

  • Shiner, B., Westgate, C. L., Bernardy, N. C., et al. (2017). Anticonvulsant medication use in veterans with posttraumatic stress disorder. Journal of Clinical Psychiatry, 78, e545–e552.

    Article  Google Scholar 

  • Sijbrandij, M., Kleiboer, A., Bisson, J. I., Barbui, C., & Cuijpers, P. (2015). Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: A systematic review and meta-analysis. Lancet Psychiatry, 2, 413–421.

    Article  PubMed  Google Scholar 

  • Steckler, T., & Risbrough, V. (2012). Pharmacological treatment of PTBS – Established and new approaches. Neuropharmacology, 62, 617–627.

    Article  CAS  PubMed  Google Scholar 

  • Stein, D. J., Ipser, J. C., & Seedat, S. (2006). Pharmacotherapy for post traumatic stress disorder (PTBS). Cochrane Database of Systematic Reviews, (1), CD002795. https://doi.org/10.1002/14651858.CD002795.pub2

  • van der Kolk, B. A., & Greenberg, M. S. (1987). The psychobiology of the trauma response: Hyperarousal, constriction, and addiction to traumatic reexposure. In B. A. van der Kolk Psychological trauma. : American Psychiatric Press.

    Google Scholar 

  • van Zuiden, M., Frijling, J. L., Nawijn, L., Koch, S. B. J., Goslings, J. C., Luitse, J. S., Biesheuvel, T. H., Honig, A., Veltman, D. J., & Olff, M. (2017). Intranasal oxytocin to prevent posttraumatic stress disorder symptoms: A randomized controlled trial in emergency department patients. Biological Psychiatry, 81, 1030–1040.

    Article  PubMed  CAS  Google Scholar 

  • Villarreal, G., Mamner, M. B., Cañive, J. M., et al. (2016). Efficacy of quetiapine monotherapy in posttraumatic stress disorder: A randomized, placebo-controlled trial. American Journal of Psychiatry, 173, 1205–1212.

    Article  Google Scholar 

  • Watts, B. V., Schnurr, P. P., Mayo, L., et al. (2013). Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. Journal of Clinical Psychiatry, 74(suppl. 6), e541–e550.

    Article  Google Scholar 

  • WHO (World Health Organization). (2013). Guidelines for the management of conditions specifically related to stress. World Health Organization.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Bauer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer-Verlag GmbH, DE, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bauer, M., Priebe, S., Severus, E. (2022). Psychopharmacotherapy of Trauma Sequelae. In: Maercker, A. (eds) Trauma Sequelae. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64057-9_19

Download citation

Publish with us

Policies and ethics